ALLMedicine™ Ebola Virus Center

Mar 12th, 2021 - Ebola virus (EBOV) is one of the most virulent pathogens that causes hemorrhagic fever and displays high mortality rates and low prognosis rates in both humans and nonhuman primates. The post-exposure antibody therapies to prevent EBOV infection a...

Feb 17th, 2021 - Introduction. The consistent emergence/reemergence of filoviruses into a world that previously lacked an approved pharmaceutical intervention parallels an experience repeatedly played-out for most other emerging pathogenic zoonotic viruses. Invest...

Feb 10th, 2021 - Sexual transmission chains of Ebola virus (EBOV) have been verified and linked to EBOV RNA persistence in semen, post-recovery. The rate of semen persistence over time, including the average duration of persistence among Ebola virus disease (EVD) ...

Feb 4th, 2021 - The severe death toll caused by the recent outbreak of Ebola virus disease reinforces the importance of developing ebolavirus prevention and treatment strategies. Here, we have explored the immunogenicity of a novel immunization regimen priming wi...

Feb 3rd, 2021 - Following vaccination with the live attenuated, recombinant vesicular stomatitis virus Indiana serotype Ebola virus (rVSV-EBOV) vaccine, persons may exhibit a transient vaccine-associated viremia. To investigate the potential for Old World sand fl...

Mar 12th, 2021 - Ebola virus (EBOV) is one of the most virulent pathogens that causes hemorrhagic fever and displays high mortality rates and low prognosis rates in both humans and nonhuman primates. The post-exposure antibody therapies to prevent EBOV infection a...

Feb 17th, 2021 - Introduction. The consistent emergence/reemergence of filoviruses into a world that previously lacked an approved pharmaceutical intervention parallels an experience repeatedly played-out for most other emerging pathogenic zoonotic viruses. Invest...

Feb 10th, 2021 - Sexual transmission chains of Ebola virus (EBOV) have been verified and linked to EBOV RNA persistence in semen, post-recovery. The rate of semen persistence over time, including the average duration of persistence among Ebola virus disease (EVD) ...

Feb 4th, 2021 - The severe death toll caused by the recent outbreak of Ebola virus disease reinforces the importance of developing ebolavirus prevention and treatment strategies. Here, we have explored the immunogenicity of a novel immunization regimen priming wi...

Feb 3rd, 2021 - Following vaccination with the live attenuated, recombinant vesicular stomatitis virus Indiana serotype Ebola virus (rVSV-EBOV) vaccine, persons may exhibit a transient vaccine-associated viremia. To investigate the potential for Old World sand fl...

Feb 26th, 2020 - The Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) unanimously recommended preexposure vaccination with the first-ever US Food and Drug Administration (FDA)–approved vaccine against Ebola v...

Dec 19th, 2019 - The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the 2014 West Africa outbreak and is behind more than ...

Dec 19th, 2019 - The US Food and Drug Administration (FDA) has approved the first vaccine for the prevention of Ebola caused by the deadly Zaire strain of the virus, which killed more than 11,000 people during the 2014 West Africa outbreak and is behind more than ...

Sep 8th, 2016 - A new approach to antibody-based therapies might one day allow clinicians to target all strains of Ebola with a broad-spectrum drug. In early research, the "Trojan horse" antibodies were effective in preventing all five varieties of Ebola from inf...

Oct 13th, 2015 - Two Ebola virus (EBOV) studies published online today in the New England Journal of Medicine translate to one piece of advice: Men who have survived Ebola virus disease (EVD) should use condoms and treat semen as a potential source of infection, a...